Cargando…

Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials: a modelled economic evaluation and threshold analysis

BACKGROUND: Long-acting injectable cabotegravir, a drug taken every 2 months, has been shown to be more effective at preventing HIV infection than daily oral tenofovir disoproxil fumarate and emtricitabine, but its cost-effectiveness in a high-prevalence setting is not known. We aimed to estimate th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jamieson, Lise, Johnson, Leigh F, Nichols, Brooke E, Delany-Moretlwe, Sinead, Hosseinipour, Mina C, Russell, Colin, Meyer-Rath, Gesine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708606/ https://www.ncbi.nlm.nih.gov/pubmed/36356603 http://dx.doi.org/10.1016/S2352-3018(22)00251-X

Ejemplares similares

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial
por: Delany-Moretlwe, Sinead, et al.
Publicado: (2022)

Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083
por: Marzinke, Mark A., et al.
Publicado: (2023)

Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077
por: Tolley, Elizabeth E., et al.
Publicado: (2020)

Assessing longitudinal patterns of depressive symptoms and the influence of symptom trajectories on HIV pre‐exposure prophylaxis adherence among adolescent girls in the HPTN 082 randomized controlled trial
por: Velloza, Jennifer, et al.
Publicado: (2021)

The impact of conditional cash transfers for HIV prevention on peer relationships: perspectives from female recipients and non-recipients in HPTN 068
por: Ndimande-Khoza, Makhosazane Nomhle, et al.
Publicado: (2022)

Men’s perspectives on the impact of female-directed cash transfers on gender relations: Findings from the HPTN 068 qualitative study
por: Khoza, Makhosazane Nomhle, et al.
Publicado: (2018)

Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial
por: Landovitz, Raphael J., et al.
Publicado: (2018)

Development of a tool to assess HIV prevention readiness of adolescent girls and young women in HPTN 082 study
por: Beauchamp, Geetha, et al.
Publicado: (2023)

Associations between friendship characteristics and HIV and HSV‐2 status amongst young South African women in HPTN‐068
por: Fearon, Elizabeth, et al.
Publicado: (2017)

Estimating the impact of HIV PrEP regimens containing long-acting injectable cabotegravir or daily oral tenofovir disoproxil fumarate/emtricitabine among men who have sex with men in the United States: a mathematical modelling study for HPTN 083
por: Mitchell, Kate M., et al.
Publicado: (2023)

Trust in the provider and accurate self-reported PrEP adherence among adolescent girls and young women in South Africa and Zimbabwe: HPTN 082 study
por: Beauchamp, Geetha, et al.
Publicado: (2023)

Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052
por: Palumbo, Philip J., et al.
Publicado: (2017)

The influence of HIV‐related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study
por: Velloza, Jennifer, et al.
Publicado: (2020)

“The role of case management in HIV treatment adherence: HPTN 078”
por: Tolley, Elizabeth E., et al.
Publicado: (2022)

Safety and tolerability of injectable Rilpivirine LA in HPTN 076: A phase 2 HIV pre-exposure prophylaxis study in women
por: Bekker, L.G., et al.
Publicado: (2020)

Community‐ and individual‐level correlates of HIV incidence in HPTN 071 (PopART)
por: Skalland, Timothy, et al.
Publicado: (2023)

Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women
por: Donnell, Deborah, et al.
Publicado: (2023)

HIV-1 diversity among young women in rural South Africa: HPTN 068
por: Sivay, Mariya V., et al.
Publicado: (2018)

Does community HIV combination prevention (HPTN 071 (PopART)) impact healthcare inequity?
por: Hansen, C, et al.
Publicado: (2022)

Including pregnant and breastfeeding people in trials of novel LAED PrEP agents: perspectives from sub‐Saharan Africa community stakeholders
por: White, Rhonda R., et al.
Publicado: (2023)

Sex, PrEP, and Stigma: Experiences with HIV Pre-exposure Prophylaxis Among New York City MSM Participating in the HPTN 067/ADAPT Study
por: Franks, Julie, et al.
Publicado: (2017)

Factors Associated With Sex-Related Pre-exposure Prophylaxis Adherence Among Men Who Have Sex With Men in New York City in HPTN 067
por: Mannheimer, Sharon, et al.
Publicado: (2019)

PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial
por: Celum, Connie, et al.
Publicado: (2021)

Analysis of HIV Diversity in HIV-Infected Black Men Who Have Sex with Men (HPTN 061)
por: Chen, Iris, et al.
Publicado: (2016)

A Randomized-Controlled Trial of Computer-based Prevention Counseling for HIV-Positive Persons (HPTN 065)
por: McKinstry, Laura A., et al.
Publicado: (2017)

Evaluation of multi-assay algorithms for identifying individuals with recent HIV infection: HPTN 071 (PopART)
por: Grant-McAuley, Wendy, et al.
Publicado: (2021)

Mass spectrometry imaging of hair identifies daily maraviroc adherence in HPTN 069/ACTG A5305
por: Rosen, Elias P., et al.
Publicado: (2023)

Cabotegravir—Global Access to Long-Acting Pre-exposure Prophylaxis for HIV
por: Pepperrell, Toby, et al.
Publicado: (2022)

Socio-Economic Status and Health Care Utilization in Rural Zimbabwe: Findings from Project Accept (HPTN 043)
por: Kevany, Sebastian, et al.
Publicado: (2012)

NIMH Project Accept (HPTN 043): Results from In-Depth Interviews with a Longitudinal Cohort of Community Members
por: Maman, Suzanne, et al.
Publicado: (2014)

Executive function associated with sexual risk in young South African women: Findings from the HPTN 068 cohort
por: Rosenberg, Molly, et al.
Publicado: (2018)

What works – reaching universal HIV testing: lessons from HPTN 071 (PopART) trial in Zambia
por: Shanaube, Kwame, et al.
Publicado: (2017)

HIV drug resistance in a community‐randomized trial of universal testing and treatment: HPTN 071 (PopART)
por: Fogel, Jessica M., et al.
Publicado: (2022)

Population‐level analysis of natural control of HIV infection in Zambia and South Africa: HPTN 071 (PopART)
por: Grant‐McAuley, Wendy, et al.
Publicado: (2023)

Pre‐exposure prophylaxis initiation and adherence among Black men who have sex with men (MSM) in three US cities: results from the HPTN 073 study
por: Wheeler, Darrell P, et al.
Publicado: (2019)

Short- and Long-Term Pharmacologic Measures of HIV Pre-exposure Prophylaxis Use Among High-Risk Men Who Have Sex With Men in HPTN 067/ADAPT
por: Velloza, Jennifer, et al.
Publicado: (2019)

Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices
por: Terris-Prestholt, Fern, et al.
Publicado: (2014)

Identification of Novel UGT1A1 Variants Including UGT1A1 454C>A through the Genotyping of Healthy Participants of the HPTN 077 Study
por: Seneviratne, Herana Kamal, et al.
Publicado: (2021)

The act of telling: South African women’s narratives of HIV status disclosure to intimate partners in the HPTN 071 (PopART) HIV prevention trial
por: Viljoen, Lario, et al.
Publicado: (2021)

Use of HIV Case Surveillance System to Design and Evaluate Site-Randomized Interventions in an HIV Prevention Study: HPTN 065
por: Donnell, Deborah J, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_9ora3rchrachom1echsm951q89